Immunofluorescent skin band test in the differential diagnosis of systemic lupus erythematosus. 1979

J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga

Forty-four uninvolved skin biopsies from lupus patients and 43 with various connective tissue diseases and nephritides other than lupus were tested for the presence of immunoglobulin deposition in the dermal-epidermal junction. Results were examined to determine their relationship to renal and clinical activity. Lupus band test (LBT) was positive in 30 (60%) SLE patients regardless of renal or clinical status. DNA-binding (p less than 0.01) and ANA (p less than 0.002) correlated to LBT. None of the other nephritides and only 2 with other connective tissue diseases were positive. LBT is a good aid in the differential diagnosis of SLE regardless of clinical or renal activity.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
April 1969, JAMA,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
February 1971, The British journal of dermatology,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
July 1970, Archives of dermatology,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
January 1971, Archives of dermatology,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
December 2004, The Medical journal of Malaysia,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
November 1964, The American journal of the medical sciences,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
January 2011, Therapeutics and clinical risk management,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
November 1972, JAMA,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
April 1983, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
J Alcocer, and J Moreno, and R Garcia-Torres, and J Gudina, and C Lavalie, and A Fraga
February 1966, Arthritis and rheumatism,
Copied contents to your clipboard!